about
Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathwayAstrocytes are central in the pathomechanisms of vanishing white matterPoor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter diseaseCerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlatesPosterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies.Vanishing white matter disease: the first reported chinese patient.Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophyMegalencephalic leukoencephalopathy with subcortical cysts: a third confirmed case with literature review.Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutationWhite matter astrocytes in health and disease.Young-onset dementiaA clinical review on megalencephaly: A large brain as a possible sign of cerebral impairment.Defective glial maturation in vanishing white matter disease.A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31.Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.Vanishing white matter disease associated with ptosis and myoclonic seizures.Vanishing white matter disease in a spanish population.Ribosomopathies: mechanisms of disease.Astrocyte Dysfunction in Developmental Neurometabolic Diseases.Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.Endoplasmic reticulum stress in disorders of myelinating cells.Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up.Disease specific therapies in leukodystrophies and leukoencephalopathies.Impaired eIF2B activity in ligodendrocytes contributes to VWMD pathogenesis.The myelin mutants as models to study myelin repair in the leukodystrophies.Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.Schizophrenia: a pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes.Progenitor cell-based treatment of the pediatric myelin disordersParadoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells.Different Eukaryotic Initiation Factor 2Bε Mutations Lead to Various Degrees of Intolerance to the Stress of Endoplasmic Reticulum in OligodendrocyteseIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B micePathoetiology of multiple sclerosis: are we barking up the wrong tree?Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gammaA point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytesMyelin under stress
P2860
Q24611933-8041B14A-1F89-42BA-9F9F-1C0604FE9C3CQ27330146-3C2347CE-1A99-4A92-BD02-3C4C42F0AAEFQ28389410-F150FB8F-4258-4632-830A-011B039209CDQ30450267-14ABB667-F819-4A03-A4DA-12E3F7118243Q31087193-A2FC53A7-9FEC-4A43-BDF3-0EA346133309Q31158484-19EA0E01-C9EC-4B0C-A29D-0A0DE65536F3Q31167723-9F636FAC-74FC-4C06-A38B-3E28580CE33EQ33372428-03FA9A99-B34F-471A-B87A-0BAC6BCF307CQ33564675-230BAA35-B342-4351-BD0B-75BED50B4BE3Q33594651-B9089D84-8D8A-4715-B381-7CA6A9CF33B5Q33660849-3CE6D8DA-A694-49C4-BD16-2A12A0657F8CQ33879555-78072796-A942-4DD6-A692-3FE8D08AAEBDQ34055875-9E0C799E-9E0C-4753-88D3-7039B7A40516Q34071458-C3B82F25-3A51-497F-BE39-46236A4480A3Q34102599-9003E493-C0F1-4618-B26B-9964DE33B534Q34103337-22A7E235-1177-4026-BFF8-63879BFD14CBQ34123857-F01CA207-0A25-4273-8115-0137C85FF473Q34133006-667EC2F8-DC11-4320-A5D8-FDB9742C5D9AQ34152320-9769FB27-98F8-4232-8E6D-70F318EB401DQ34432161-E2CDCC69-3F82-46C8-93C7-C0DE7A3792EAQ34454066-EFF77701-52EA-4E41-BB46-40E270DE313EQ34679071-F37ABAC1-B124-4DEF-A842-D93470EBB171Q34786420-9E6B15CF-14C7-4D95-875F-3EBF389ACB05Q34962824-7AEC9742-4143-4CF4-B545-EA96010C4062Q35168282-536FE130-9878-416F-9FF3-72691BCC2A76Q35328494-199E14E8-7B83-44F3-96EE-58FBF3D78DF4Q35356812-D12F9EC4-8D79-4E6C-9FAF-DC27AD272986Q35648148-32FB86C3-EF98-4603-8A7A-044F5AAD05B1Q35843362-8C5FAD34-3899-4774-A8B8-C2CA24647A1DQ35909867-A4FD5505-30E4-4B48-A7CF-8E36C950D4F6Q35983132-718729B6-EBEB-482D-ADCC-68A050A070B9Q36182431-524D36EF-DC88-443D-9323-A3ECA7B9E9CAQ36523093-4DFD6C3A-8F79-48DB-A45D-4AF85B7A8998Q36747748-A6B6BC9B-4563-48B2-850E-81517239D7DDQ36750041-F8E234A9-7E09-4810-90DA-B5AED32BCAE5Q36904407-69B00ECE-47DC-4969-9FC3-060DAFF6C5EFQ36943108-8AD91350-9C6D-4F28-B30C-E7091E82BD51Q36972922-D2097BDD-7A98-48C6-864C-E1F6B98B689CQ37099475-A71C831B-6125-4AF6-A0C0-D1999D442958Q37426514-8461FAA8-3B39-4DD3-9055-C278DDF9C505
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Vanishing white matter disease.
@ast
Vanishing white matter disease.
@en
type
label
Vanishing white matter disease.
@ast
Vanishing white matter disease.
@en
prefLabel
Vanishing white matter disease.
@ast
Vanishing white matter disease.
@en
P2093
P1433
P1476
Vanishing white matter disease.
@en
P2093
Gert C Scheper
Jan C Pronk
Marjo S van der Knaap
P304
P356
10.1016/S1474-4422(06)70440-9
P577
2006-05-01T00:00:00Z